small molecule

SYNTHROID

LEVOTHYROXINE SODIUM

Loss of exclusivity—loss of exclusivity

CompanyAbbVie Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand name	SYNTHROID
Active ingredient	LEVOTHYROXINE SODIUM
Strength	0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
Dosage form	TABLET
Route	ORAL
Modality	Small molecule
FDA approval	July 2002
Marketing status	RX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.